Patent Assignment
Reel/Frame 031432/0123
Change of Name
Recorded: 2013-10-17
Pages: 5
Assignor
RIB-X PHARMACEUTICALS, INC.
Executed: 2013-10-07
Assignee
MELINTA THERAPEUTICS, INC.
300 GEORGE STREET, SUITE 301, NEW HAVEN, CONNECTICUT, 06511
Covered Properties
(13)
Crystals of the Large Ribosomal Subunit
Patent:
6,638,908 →
Application:
09/635,708 →
Modulators of Ribosomal Function and Identification Thereof
Modulators of Ribosomal Function and Identification Thereof
Method of Identifying Molecules That Bind to the Large Ribosomal Subunit
Determination and Uses of the Atomic Structures of Ribosomes and Ribosomal Subunits and Their Ligand Complexes
Crystals of the Large Ribosomal Subunit
Ribosome Structure and Protein Synthesis Inhibitors
Protein Synthesis Modulators
Patent:
8,374,794 →
Application:
12/072,980 →
Protein Synthesis Modulators
Patent:
8,428,884 →
Application:
12/074,200 →
Ribosome Structure and Protein Synthesis Inhibitors
Protein Synthesis Modulators
Application:
13/764,363 →
Publication:
US 2013/0344562
Protein Synthesis Modulators
Application:
13/834,982 →
Publication:
US 2014/0051592
Ribosome Structure and Protein Synthesis Inhibitors
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 12, 2012
From: WIMBERLY, BRIAN
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 029453/0626 →
Assignment of Assignor's Interest
Sep 12, 2013
From: WIMBERLY, BRIAN
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 031197/0149 →
Assignment of Assignor's Interest
Dec 13, 2013
From: SUTCLIFFE, JOYCE A; OYELERE, ADEGBOYEGA K; IPPOLITO, JOSEPH A
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 031780/0329 →
Assignment of Assignor's Interest
Dec 13, 2013
From: STEITZ, THOMAS A; MOORE, PETER B
To: YALE UNIVERSITY
Reel/Frame 031780/0339 →
Security Interest
Jun 28, 2017
From: MELINTA THERAPEUTICS, INC.
To: SUCHARD SA LLC
Reel/Frame 042854/0753 →
Release of Security Interest
Jan 5, 2018
From: SUCHARD SA LLC
To: MELINTA SUBSIDIARY CORP. (F/K/A MELINTA THERAPEUTICS, INC.)
Reel/Frame 044547/0939 →
Security Interest
Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Merger and Change of Name
Aug 30, 2018
From: MELINTA THERAPEUTICS, INC.; MELINTA SUBSIDIARY CORP.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 046752/0975 →
Security Interest
Mar 19, 2019
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; MELINTA SUBSIDIARY CORP.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 048637/0784 →
Intellectual Property Security Agreement
Dec 22, 2020
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 054836/0765 →
Amended and Restated Intellectual Property Security Agreement
Aug 25, 2022
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 061314/0459 →
Termination and Release of Intellectual Property Security Agreement (Patents) at Reel 054836 and Frame 0765 and Reel 061314 and 0459
Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: MELINTA THERAPEUTICS, LLC
Reel/Frame 072772/0097 →